LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX),a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce its second quarter 2011 financial results and an operational update in a press release to be issued before the market opens on Monday, August 8, 2011.
